Homepage
AGING Analysis Report
Jun 7, 2026
19 days ago · 100% complete

Hormel Foods Corporation

HRL NYSE Categories PDF
Consumer Defensive · Packaged Foods
Austin, MN 55912-3680, United States IPO 1980 hormelfoods.com Updated Jun 7, 1:44pm
Price
$23.62
Market Cap
$13.0B
Employees
20,000
Beta
0.34
Avg Volume
5,426,174
CEO
Jeffrey Ettinger
Business Description

Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and food products to retail, foodservice, deli, and commercial customers in the United States and internationally. The company operates through four segments: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, and International & Other. It provides various perishable products that include fresh meats, frozen items, refrigerated meal solutions, sausages, hams, guacamoles, and bacons; and shelf-stable products comprising canned luncheon meats, nut butters, snack nuts, chilies, shelf-stable microwaveable meals, hashes, stews, tortillas, salsas, tortilla chips, and others. The company also engages in the processing, marketing, and sale of branded and unbranded pork, beef, poultry, and turkey products, as well as offers nutritional food products and supplements, desserts and drink mixes, and industrial gelatin products. It sells its products primarily under the SKIPPY, SPAM, Hormel, Natural Choice, Applegate, Justin's, Jennie-O, Café H, Herdez, Black Label, Sadler's, Columbus, Gatherings, Herdez, Wholly, Columbus, Planters, NUT-rition, Planters Cheez Balls, Corn Nuts, etc. brand names through sales personnel, independent brokers, and distributors. The company was formerly known as Geo. A. Hormel & Company and changed its name to Hormel Foods Corporation in January 1995. Hormel Foods Corporation was founded in 1891 and is headquartered in Austin, Minnesota.

Business History
Generated: Jun 7, 2026 5:17pm
Price Overview
Last updated: Jun 7, 2026 5:14pm (19d ago)
$23.62
+0.33 (+1.42%)
Day Range
$23.32 – $23.73
52-Week Range
$19.70 – $31.86
50-Day MA
$21.44
200-Day MA
$23.46
Volume
3,229,360.00
Analyst Price Targets
Low $22.00
Consensus $25.67
High $30.00
(20 analysts)
Share Structure
Outstanding 550,314,959.00
Float 290,571,802.00
Free Float 52.8%
Normal free float — 52.8% of shares trade freely, ~47.2% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Last updated: Jun 7, 2026 5:20pm (19d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 7, 2026 5:20pm (19d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
Industry comparison last run: Jun 7, 2026 5:16pm
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
27.85
Stock Price: $23.62
EPS (Diluted): 0.87
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
1.65
Stock Price: $23.62
Total Equity: $7.90B
Shares: 550,496,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
14.55
Market Cap: $13.00B
Total Debt: $2.86B
Cash: $670.68M
EBITDA: $1.01B
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$15.2B
Market Cap: $13.00B
Total Debt: $2.86B
Cash: $670.68M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
15.6%
Gross Profit: $1.89B
Revenue: $12.11B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
5.9%
Operating Income: $718.60M
Revenue: $12.11B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
4.0%
Net Income: $478.20M
Revenue: $12.11B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
5.9%
Net Income: $478.20M
Total Equity: $7.90B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
4.4%
Operating Income: $718.60M
Tax Rate: 28.0%
Equity: $7.90B
Total Debt: $2.86B
Cash: $670.68M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
2.47
Current Assets: $3.41B
Current Liabilities: $1.38B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.36
Short-Term Debt: $6.65M
Long-Term Debt: $2.85B
Total Debt: $2.86B
Total Equity: $7.90B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$21.99
Revenue: $12.11B
Shares: 550,496,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$14.35
Total Equity: $7.90B
Shares: 550,496,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$0.97
Operating CF: $845.25M
CapEx: -$310.90M
Shares: 550,496,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
4.8%
Last Dividend: N/A
Stock Price: $23.62
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $478.20M
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jun 7, 2026 5:16pm
Compares HRL against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis
Last run: Jun 7, 2026 5:19:18 pm

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
Not applicable for Mature Earner companies
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
Not applicable for Mature Earner companies
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
Not applicable for Mature Earner companies
4h Dividend Discount Model — For dividend/income stocks only
Not applicable for Mature Earner companies
4i Book Value Analysis — For deep value / turnaround stocks only
Not applicable for Mature Earner companies
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
Not applicable for Mature Earner companies
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 7, 2026 5:20pm (19d ago)
Metric 2021 2022 2023 2024 2025
Revenue $11.4B $12.5B $12.1B $11.9B $12.1B
Cost of Revenue $9.5B $10.3B $10.1B $9.9B $10.2B
Gross Profit $1.9B $2.2B $2.0B $2.0B $1.9B
Operating Expenses $805.3M $852.1M $927.8M $954.2M $1.2B
Operating Income $1.1B $1.3B $1.1B $1.1B $718.6M
Net Income $908.8M $1,000.0M $793.6M $805.0M $478.2M
EBITDA $1.4B $1.6B $1.3B $1.4B $1.0B
EPS $1.68 $1.84 $1.45 $1.47 $0.87
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 7, 2026 5:15pm (19d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $613.5M $982.1M $736.5M $741.9M $670.7M
Total Current Assets $2.9B $3.6B $3.3B $3.2B $3.4B
Total Assets $12.7B $13.3B $13.4B $13.4B $13.4B
Current Liabilities $1.4B $1.5B $2.3B $1.4B $1.4B
Long-Term Debt $3.3B $3.3B $2.4B $2.9B $2.9B
Total Liabilities $5.7B $5.8B $5.7B $5.4B $5.5B
Total Equity $7.0B $7.5B $7.7B $8.0B $7.9B
Retained Earnings $6.9B $7.3B $7.5B $7.7B $7.5B
Cash Flow (Annual)
Last updated: Jun 7, 2026 5:20pm (19d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $1.0B $1.1B $1.0B $1.3B $845.3M
Capital Expenditure -$230.2M -$277.7M -$270.2M -$256.4M -$310.9M
Free Cash Flow $771.7M $857.3M $777.6M $1.0B $534.3M
Acquisitions (net) -$3.4B $2.4M -$427.7M $32.0M $18.2M
Debt Repayment
Dividends Paid
Stock Buybacks -$20.0M $0 -$12.3M $0 $0
Net Change in Cash -$1.1B $368.6M -$245.6M $5.3M -$71.2M
Analyst Estimates (Annual)
Last updated: Jun 7, 2026 5:15pm (19d ago)
Metric 2025 2026 2027 2028
Revenue $12.1B
$12.1B – $12.2B
$12.3B
$12.2B – $12.3B
$12.5B
$12.3B – $12.6B
$12.8B
$12.8B – $12.8B
EBITDA $1.4B
$1.4B – $1.4B
$1.4B
$1.4B – $1.4B
$1.4B
$1.4B – $1.4B
$1.4B
$1.4B – $1.4B
Net Income $750.6M
$745.0M – $756.2M
$755.9M
$711.1M – $852.2M
$844.6M
$787.5M – $899.2M
$876.5M
$867.0M – $982.6M
EPS
Growth Trends (YoY %)
Last updated: Jun 7, 2026 5:20pm (19d ago)
Metric 2022 2023 2024 2025
Revenue Growth +9.4% -2.8% -1.6% +1.6%
Gross Profit Growth +12.3% -7.6% +1.1% -6.4%
Operating Income Growth +16.9% -18.3% -0.4% -32.7%
Net Income Growth +10.0% -20.6% +1.4% -40.6%
EBITDA Growth +14.3% -15.0% +2.5% -26.8%
Insider Trading (Recent)
Last updated: Jun 7, 2026 5:19pm (19d ago)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-06-09 Bonifant William W. A-Award 34,900.00 $23.98 $836,902
2026-06-09 Bonifant William W. A-Award 5,734.00 $0.00 $0
2026-06-09 Borrelli Domenic A-Award 50,800.00 $23.98 $1.2M
2026-06-09 Borrelli Domenic A-Award 8,341.00 $0.00 $0
2026-04-27 Aakre D Scott F-InKind 1,722.00 $21.47 $36,971
2026-04-14 Bonifant William W. A-Award 87,700.00 $20.76 $1.8M
2026-04-14 Bonifant William W. A-Award 12,043.00 $0.00 $0
2026-03-31 Schoneman Debbra L. A-Award 1,332.78 $22.65 $30,187
2026-03-31 Bhojwani Gary C. A-Award 2,665.56 $22.65 $60,375
2026-03-31 Newlands William A A-Award 6,721.85 $22.65 $152,250
2026-03-31 White Steven Andrew A-Award 2,665.56 $22.65 $60,375
2026-03-31 Policinski Christopher J. A-Award 2,491.72 $22.65 $56,437
2026-03-09 Bonifant William W. 0.00 $0.00 $0
2026-03-18 White Steven Andrew G-Gift 5,405.00 $0.00 $0
2026-03-18 White Steven Andrew G-Gift 5,405.00 $0.00 $0
2026-02-23 Borrelli Domenic 0.00 $0.00 $0
2026-02-02 Ghingo John F A-Award 201,000.00 $24.46 $4.9M
2026-02-02 Ghingo John F A-Award 32,707.00 $0.00 $0
2026-02-02 Bhojwani Gary C. A-Award 6,541.00 $0.00 $0
2026-02-02 Aakre D Scott A-Award 6,541.00 $0.00 $0
Dividend History (Last 20)
Last updated: Jun 7, 2026 5:15pm (19d ago)
Date Dividend Declaration Record Payment
2026-07-13 $0.29 2026-05-18 2026-07-13 2026-08-17
2026-04-13 $0.29 2026-03-23 2026-04-13 2026-05-15
2026-01-12 $0.29 2025-11-24 2026-01-12 2026-02-17
2025-10-14 $0.29 2025-09-22 2025-10-14 2025-11-17
2025-07-14 $0.29 2025-05-19 2025-07-14 2025-08-15
2025-04-14 $0.29 2025-03-24 2025-04-14 2025-05-15
2025-01-13 $0.29 2024-11-25 2025-01-13 2025-02-18
2024-10-15 $0.28 2024-09-23 2024-10-15 2024-11-15
2024-07-15 $0.28 2024-05-20 2024-07-15 2024-08-15
2024-04-12 $0.28 2024-03-25 2024-04-15 2024-05-15
2024-01-12 $0.28 2023-11-20 2024-01-16 2024-02-15
2023-10-13 $0.28 2023-09-25 2023-10-16 2023-11-15
2023-07-14 $0.28 2023-05-22 2023-07-17 2023-08-15
2023-04-14 $0.28 2023-03-27 2023-04-17 2023-05-15
2023-01-13 $0.28 2022-11-21 2023-01-17 2023-02-15
2022-10-14 $0.26 2022-09-26 2022-10-17 2022-11-15
2022-07-08 $0.26 2022-05-23 2022-07-11 2022-08-15
2022-04-08 $0.26 2022-03-28 2022-04-11 2022-05-16
2022-01-14 $0.26 2021-11-22 2022-01-18 2022-02-15
2021-10-15 $0.25 2021-09-27 2021-10-18 2021-11-15
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for HRL — it's generated by the pipeline (market-narrative step).
Delvantic AI Findings
Independent analyst synthesis · Delvantic - Cairn AI · generated 2026-06-07 17:19:56
Reviews the pipeline's own verdicts
Verdict Overvalued but the synthesis overshoots — fair value $18-20 not $13; avoid at $23.62, revisit on dividend scare or sub-$18 print.

Looking at the raw quarterly tape first: revenue has flatlined around $2.97-3.19B per quarter for two years with zero CAGR, and the Oct-2025 quarter printed a $56M net loss — that's the entire story of FY25's earnings collapse from $805M to $478M. Strip that quarter out and the other three FY25 quarters annualize to roughly $715M in NI, suggesting the "structural impairment" thesis may be overstating what looks like a single charge-laden quarter (likely Planters/Jennie-O writedowns or restructuring). The two FY26 quarters posted to date ($157.5M and $181.8M) annualize to ~$680M — soft but not catastrophic, and net margin has recovered to 5.3-6.0% from the Q4 disaster. FCF of $534M on a $13B market cap is a 4.1% yield, and the 4.85% dividend yield is barely covered by FCF ($534M FCF vs. ~$630M in dividends at current payout) — that's the actual fragility, not the narrative.

The synthesis verdict of $12.91 fair value (-45% downside) strikes me as aggressively wrong. A DCF that spits out $12.91 for a company doing $534M of FCF, $845M of OCF, with a 2.47 current ratio and modest leverage, is using either a punitive discount rate or terminal growth assumption that ignores that Hormel still owns SPAM, Skippy, Applegate, and Jennie-O — brands with real shelf space even if pricing power has eroded. EV/EBITDA of 14.5x is elevated for a no-growth packaged food name (peers like CAG, CPB trade 9-11x), so I'd peg fair value closer to $18-20 on a 10-11x EV/EBITDA — meaningful downside from $23.62 but nowhere near 45%. The Market Forces "deteriorating value trap" framing is directionally right; the synthesis number is too aggressive.

The contrarian read: insider activity is all awards and inkind tax withholding — zero open-market selling, which is notable for a stock down 26% from highs where you'd expect at least some discretionary trimming if insiders shared the bear thesis. Q1 and Q2 FY26 margins recovering to 5.3-6% suggests the Oct-2025 quarter was a kitchen-sink event, not a new run-rate. If FY26 lands at $750-800M NI (consensus-ish), the stock trades ~16-17x forward — premium to the group but not absurd for a Dividend King with 57 years of increases. The narrative model is correct that the premium is a "dividend aristocrat tax," but that tax has been durable for decades and won't unwind absent a cut. Dividend coverage is the actual swing factor, and at 1.0-1.1x FCF coverage it's tight but not broken.

Where the data is thin: balance sheet shows no total debt or equity figures, which matters because Hormel carried ~$3.3B in long-term debt historically — without that, leverage and true EV are guesses. The TTM-tagged metrics (PE 27.85, ROE 5.86%, ROIC 4.38%) are dragged down by that one bad quarter and will mechanically improve as it rolls off. ROIC of 4.4% is genuinely poor and below WACC — that's the real long-term problem, not the quarterly noise. I dissent from the synthesis's $12.91 (too punitive, ignores brand equity floor and a likely one-time charge) but agree with the direction. The narrative layer nails it: you're paying ~$8-10 of narrative premium per share for aristocrat status, and that premium is fragile to a dividend cut but durable otherwise. Fair value $18-20, current $23.62 = 15-25% overvalued, not 45%. Wait for either (a) a dividend cut that resets the narrative and offers $15-handle entry, or (b) two consecutive quarters of margin recovery to 6.5%+ that re-rates the multiple. Holding here earns you 4.85% yield with capital risk skewed negative.

GPT Critique
Second-opinion review · gpt-4o · generated 2026-06-07 17:20:01
Reviews the Opus findings above
Verdict I agree with Opus — overvalued at $23.62, but I'd peg fair value closer to $18-$20, recognizing brand strength and recent margin recovery.

Upon examining Hormel Foods Corporation, what stands out is the company's recent financial performance and its implications for its valuation. Hormel's revenue has been relatively stable, fluctuating between $2.97 billion and $3.19 billion per quarter over the past two years. However, the company's profitability has suffered notably, with a dramatic net income drop from $805 million in 2024 to $478 million in 2025. This decline is largely attributed to a $56 million loss in the fourth quarter of 2025, a stark contrast to the otherwise stable earnings in other quarters. The company's free cash flow of $534 million suggests a 4.1% yield, which, coupled with a dividend yield of 4.85%, indicates tight but manageable coverage — a critical point given the company's status as a dividend aristocrat.

I agree with Opus regarding the overvaluation of Hormel's stock, though I find the synthesis's fair value of $12.91 excessively conservative. Opus rightly points out that the synthesis may have employed an overly punitive discount rate or growth assumption, ignoring the value of Hormel's established brand portfolio. However, the EV/EBITDA ratio of 14.5x is indeed high for a no-growth entity in the packaged foods sector, suggesting that a fair value closer to $18-$20, as Opus suggests, is reasonable. This accounts for the strength of Hormel's brands and the potential for margin stabilization, albeit not expansion.

Opus also makes a compelling argument against the narrative of structural impairment, noting the recovery of net margins to 5.3-6.0% in early 2026, which supports the notion that the Q4 2025 results were an anomaly. I concur with this assessment; the absence of insider selling during the stock's decline implies a different internal perspective than the market's bearish stance. However, I disagree slightly with Opus's conclusion on dividend safety. While Hormel's dividend yield is currently barely covered by free cash flow, the company's historical ability to maintain its dividend streak suggests resilience, though the risk of a cut cannot be entirely dismissed.

A careful skeptic of both our views might argue that the broader market forces, including rising commodity costs and shifting consumer preferences towards healthier options, could impose long-term pressure on Hormel's margins and pricing power. They might also point to the lack of detailed debt figures as a risk factor for assessing true enterprise value and leverage.

Community AI Feedback
No community reviews yet for HRL. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30